Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City

J Allergy Clin Immunol Pract. 2021 Jan;9(1):490-493.e2. doi: 10.1016/j.jaip.2020.09.052. Epub 2020 Oct 8.

Authors

Hsi-En Ho¹, Sheryl Mathew¹, Michael J Peluso², Charlotte Cunningham-Rundles³

Affiliations

¹ Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
² Department of Medicine, University of California, San Francisco, Calif.
³ Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: charlotte.cunningham-rundles@mssm.edu.

No abstract available

MeSH terms

Adult
Aged
Aged, 80 and over
COVID-19 / epidemiology*
COVID-19 / pathology*
COVID-19 / therapy
Child
Comorbidity
Female
Hospitalization / statistics & numerical data
Humans
Immunologic Deficiency Syndromes / epidemiology*
Immunologic Deficiency Syndromes / pathology*
Infant
Male
Middle Aged
New York City / epidemiology
Patient Outcome Assessment*
Respiration, Artificial / statistics & numerical data
Risk Factors
SARS-CoV-2
Severity of Illness Index
Young Adult

Grants and funding

T32 AI060530/AI/NIAID NIH HHS/United States